Hologic, Inc. (HOLX)
USD 58.46
(-4.59%)
USD 58.46
(-4.59%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 | 4.03 Billion USD | -0.0% |
| 2023 | 4.03 Billion USD | -17.12% |
| 2022 | 4.86 Billion USD | -13.66% |
| 2021 | 5.63 Billion USD | 49.14% |
| 2020 | 3.77 Billion USD | 12.15% |
| 2019 | 3.36 Billion USD | 4.64% |
| 2018 | 3.21 Billion USD | 5.2% |
| 2017 | 3.05 Billion USD | 7.98% |
| 2016 | 2.83 Billion USD | 4.72% |
| 2015 | 2.7 Billion USD | 6.89% |
| 2014 | 2.53 Billion USD | 1.54% |
| 2013 | 2.49 Billion USD | 24.45% |
| 2012 | 2 Billion USD | 11.92% |
| 2011 | 1.78 Billion USD | 6.54% |
| 2010 | 1.67 Billion USD | 2.59% |
| 2009 | 1.63 Billion USD | -2.23% |
| 2008 | 1.67 Billion USD | 126.78% |
| 2007 | 738.36 Million USD | 59.59% |
| 2006 | 462.68 Million USD | 60.83% |
| 2005 | 287.68 Million USD | 25.79% |
| 2004 | 228.7 Million USD | 12.09% |
| 2003 | 204.03 Million USD | 7.28% |
| 2002 | 190.19 Million USD | 6.56% |
| 2001 | 178.49 Million USD | 90.4% |
| 2000 | 93.74 Million USD | 11.47% |
| 1999 | 84.1 Million USD | -27.25% |
| 1998 | 115.6 Million USD | 8.34% |
| 1997 | 106.7 Million USD | 20.98% |
| 1996 | 88.2 Million USD | 103.23% |
| 1995 | 43.4 Million USD | 12.73% |
| 1994 | 38.5 Million USD | 55.24% |
| 1993 | 24.8 Million USD | -5.34% |
| 1992 | 26.2 Million USD | 53.22% |
| 1991 | 17.1 Million USD | -13.64% |
| 1990 | 19.8 Million USD | 73.68% |
| 1989 | 11.4 Million USD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q4 | 987.9 Million USD | -2.32% |
| 2024 Q2 | 1.01 Billion USD | 0.46% |
| 2024 Q3 | 1.01 Billion USD | -0.63% |
| 2024 Q1 | 1.01 Billion USD | 7.17% |
| 2023 Q2 | 1.02 Billion USD | -4.44% |
| 2023 Q4 | 945.3 Million USD | -3.97% |
| 2023 Q3 | 984.4 Million USD | -4.1% |
| 2023 FY | 4.03 Billion USD | -17.12% |
| 2023 Q1 | 1.07 Billion USD | 12.69% |
| 2022 Q4 | 953.2 Million USD | -4.94% |
| 2022 Q3 | 1 Billion USD | -30.16% |
| 2022 Q1 | 1.47 Billion USD | 11.73% |
| 2022 FY | 4.86 Billion USD | -13.66% |
| 2022 Q2 | 1.43 Billion USD | -2.41% |
| 2021 FY | 5.63 Billion USD | 49.14% |
| 2021 Q1 | 1.6 Billion USD | 19.51% |
| 2021 Q2 | 1.53 Billion USD | -4.49% |
| 2021 Q3 | 1.16 Billion USD | -24.02% |
| 2021 Q4 | 1.31 Billion USD | 12.69% |
| 2020 Q4 | 1.34 Billion USD | 63.69% |
| 2020 Q3 | 822.9 Million USD | 8.83% |
| 2020 Q2 | 756.1 Million USD | -11.1% |
| 2020 FY | 3.77 Billion USD | 12.15% |
| 2020 Q1 | 850.5 Million USD | -1.77% |
| 2019 FY | 3.36 Billion USD | 4.64% |
| 2019 Q1 | 830.7 Million USD | 2.11% |
| 2019 Q2 | 818.4 Million USD | -1.48% |
| 2019 Q3 | 852.4 Million USD | 4.15% |
| 2019 Q4 | 865.8 Million USD | 1.57% |
| 2018 Q3 | 824 Million USD | 4.4% |
| 2018 Q2 | 789.3 Million USD | -0.23% |
| 2018 Q1 | 791.1 Million USD | -1.47% |
| 2018 FY | 3.21 Billion USD | 5.2% |
| 2018 Q4 | 813.5 Million USD | -1.27% |
| 2017 Q2 | 715.4 Million USD | -2.59% |
| 2017 Q3 | 806.1 Million USD | 12.68% |
| 2017 Q4 | 802.9 Million USD | -0.4% |
| 2017 Q1 | 734.4 Million USD | 1.05% |
| 2017 FY | 3.05 Billion USD | 7.98% |
| 2016 Q4 | 726.8 Million USD | 1.31% |
| 2016 Q1 | 695.2 Million USD | -1.08% |
| 2016 FY | 2.83 Billion USD | 4.72% |
| 2016 Q3 | 717.4 Million USD | 3.48% |
| 2016 Q2 | 693.3 Million USD | -0.27% |
| 2015 Q3 | 693.9 Million USD | 5.86% |
| 2015 Q2 | 655.5 Million USD | 0.41% |
| 2015 Q1 | 652.8 Million USD | -1.18% |
| 2015 FY | 2.7 Billion USD | 6.89% |
| 2015 Q4 | 702.8 Million USD | 1.28% |
| 2014 Q3 | 632.6 Million USD | 1.21% |
| 2014 Q4 | 660.6 Million USD | 4.43% |
| 2014 FY | 2.53 Billion USD | 1.54% |
| 2014 Q1 | 612.44 Million USD | -1.55% |
| 2014 Q2 | 625 Million USD | 2.05% |
| 2013 FY | 2.49 Billion USD | 24.45% |
| 2013 Q4 | 622.11 Million USD | -0.64% |
| 2013 Q3 | 626.13 Million USD | 2.2% |
| 2013 Q2 | 612.66 Million USD | -2.96% |
| 2013 Q1 | 631.36 Million USD | 7.27% |
| 2012 FY | 2 Billion USD | 11.92% |
| 2012 Q1 | 472.71 Million USD | 1.21% |
| 2012 Q3 | 470.22 Million USD | -0.2% |
| 2012 Q4 | 588.54 Million USD | 25.16% |
| 2012 Q2 | 471.16 Million USD | -0.33% |
| 2011 Q3 | 451.08 Million USD | 2.83% |
| 2011 Q1 | 432.57 Million USD | 1.0% |
| 2011 Q2 | 438.65 Million USD | 1.41% |
| 2011 FY | 1.78 Billion USD | 6.54% |
| 2011 Q4 | 467.04 Million USD | 3.54% |
| 2010 Q2 | 418.11 Million USD | 1.37% |
| 2010 FY | 1.67 Billion USD | 2.59% |
| 2010 Q3 | 420.69 Million USD | 0.62% |
| 2010 Q4 | 428.29 Million USD | 1.81% |
| 2010 Q1 | 412.44 Million USD | 2.4% |
| 2009 Q2 | 402.01 Million USD | -6.34% |
| 2009 Q1 | 429.23 Million USD | -3.0% |
| 2009 Q3 | 403.12 Million USD | 0.28% |
| 2009 Q4 | 402.76 Million USD | -0.09% |
| 2009 FY | 1.63 Billion USD | -2.23% |
| 2008 Q2 | 431.04 Million USD | 16.05% |
| 2008 Q4 | 442.51 Million USD | 3.03% |
| 2008 Q3 | 429.49 Million USD | -0.36% |
| 2008 Q1 | 371.44 Million USD | 83.37% |
| 2008 FY | 1.67 Billion USD | 126.78% |
| 2007 FY | 738.36 Million USD | 59.59% |
| 2007 Q1 | 163.21 Million USD | 5.94% |
| 2007 Q2 | 181.08 Million USD | 10.95% |
| 2007 Q3 | 191.5 Million USD | 5.75% |
| 2007 Q4 | 202.56 Million USD | 5.77% |
| 2006 Q1 | 87.95 Million USD | 12.45% |
| 2006 Q4 | 154.05 Million USD | 28.72% |
| 2006 Q3 | 119.68 Million USD | 18.52% |
| 2006 Q2 | 100.98 Million USD | 14.81% |
| 2006 FY | 462.68 Million USD | 60.83% |
| 2005 Q2 | 69.23 Million USD | 4.63% |
| 2005 Q3 | 74.05 Million USD | 6.96% |
| 2005 Q4 | 78.21 Million USD | 5.62% |
| 2005 FY | 287.68 Million USD | 25.79% |
| 2005 Q1 | 66.17 Million USD | 3.48% |
| 2004 Q3 | 59.22 Million USD | 6.43% |
| 2004 Q2 | 55.64 Million USD | 11.56% |
| 2004 Q4 | 63.94 Million USD | 7.98% |
| 2004 Q1 | 49.88 Million USD | -4.71% |
| 2004 FY | 228.7 Million USD | 12.09% |
| 2003 FY | 204.03 Million USD | 7.28% |
| 2003 Q4 | 52.34 Million USD | -0.08% |
| 2003 Q2 | 50.33 Million USD | 2.8% |
| 2003 Q3 | 52.38 Million USD | 4.08% |
| 2003 Q1 | 48.96 Million USD | -0.77% |
| 2002 Q4 | 49.34 Million USD | 3.59% |
| 2002 Q2 | 46.06 Million USD | -2.28% |
| 2002 Q1 | 47.14 Million USD | 4.16% |
| 2002 FY | 190.19 Million USD | 6.56% |
| 2002 Q3 | 47.63 Million USD | 3.41% |
| 2001 Q3 | 44.93 Million USD | 2.74% |
| 2001 Q4 | 45.26 Million USD | 0.72% |
| 2001 FY | 178.49 Million USD | 90.4% |
| 2001 Q2 | 43.74 Million USD | -1.6% |
| 2001 Q1 | 44.45 Million USD | 63.92% |
| 2000 Q1 | 21.3 Million USD | 5.97% |
| 2000 FY | 93.74 Million USD | 11.47% |
| 2000 Q2 | 23.25 Million USD | 9.16% |
| 2000 Q3 | 22.08 Million USD | -5.03% |
| 2000 Q4 | 27.11 Million USD | 22.8% |
| 1999 Q2 | 18.8 Million USD | -21.34% |
| 1999 FY | 84.1 Million USD | -27.25% |
| 1999 Q1 | 23.9 Million USD | -12.77% |
| 1999 Q4 | 20.1 Million USD | 0.5% |
| 1999 Q3 | 20 Million USD | 6.38% |
| 1998 FY | 115.6 Million USD | 8.34% |
| 1998 Q2 | 30.2 Million USD | 15.71% |
| 1998 Q3 | 33.6 Million USD | 11.26% |
| 1998 Q4 | 27.4 Million USD | -18.45% |
| 1998 Q1 | 26.1 Million USD | 6.1% |
| 1997 Q2 | 28 Million USD | 3.32% |
| 1997 Q4 | 24.6 Million USD | -8.55% |
| 1997 Q3 | 26.9 Million USD | -3.93% |
| 1997 FY | 106.7 Million USD | 20.98% |
| 1997 Q1 | 27.1 Million USD | -15.05% |
| 1996 Q2 | 18.8 Million USD | 27.03% |
| 1996 Q4 | 31.9 Million USD | 39.91% |
| 1996 Q3 | 22.8 Million USD | 21.28% |
| 1996 Q1 | 14.8 Million USD | 14.73% |
| 1996 FY | 88.2 Million USD | 103.23% |
| 1995 Q2 | 9 Million USD | -11.76% |
| 1995 Q3 | 11.3 Million USD | 25.56% |
| 1995 Q1 | 10.2 Million USD | 2.0% |
| 1995 Q4 | 12.9 Million USD | 14.16% |
| 1995 FY | 43.4 Million USD | 12.73% |
| 1994 Q2 | 9.9 Million USD | 30.26% |
| 1994 Q1 | 7.6 Million USD | 20.63% |
| 1994 FY | 38.5 Million USD | 55.24% |
| 1994 Q4 | 10 Million USD | -8.26% |
| 1994 Q3 | 10.9 Million USD | 10.1% |
| 1993 Q2 | 6.3 Million USD | 16.67% |
| 1993 FY | 24.8 Million USD | -5.34% |
| 1993 Q4 | 6.3 Million USD | -4.55% |
| 1993 Q1 | 5.4 Million USD | -23.94% |
| 1993 Q3 | 6.6 Million USD | 4.76% |
| 1992 FY | 26.2 Million USD | 53.22% |
| 1992 Q4 | 7.1 Million USD | -4.05% |
| 1992 Q1 | 5.3 Million USD | 17.78% |
| 1992 Q2 | 6.4 Million USD | 20.75% |
| 1992 Q3 | 7.4 Million USD | 15.63% |
| 1991 Q1 | 3.9 Million USD | -18.75% |
| 1991 Q2 | 4.2 Million USD | 7.69% |
| 1991 Q3 | 4.5 Million USD | 7.14% |
| 1991 Q4 | 4.5 Million USD | 0.0% |
| 1991 FY | 17.1 Million USD | -13.64% |
| 1990 FY | 19.8 Million USD | 73.68% |
| 1990 Q1 | 3.9 Million USD | 14.71% |
| 1990 Q4 | 4.8 Million USD | -20.0% |
| 1990 Q3 | 6 Million USD | 22.45% |
| 1990 Q2 | 4.9 Million USD | 25.64% |
| 1989 Q2 | 2.6 Million USD | 18.18% |
| 1989 Q3 | 3.2 Million USD | 23.08% |
| 1989 Q4 | 3.4 Million USD | 6.25% |
| 1989 FY | 11.4 Million USD | 0.0% |
| 1989 Q1 | 2.2 Million USD | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Akoya Biosciences, Inc. | 96.63 Million USD | -4070.728% |
| AngioDynamics, Inc. | 303.91 Million USD | -1226.132% |
| AtriCure, Inc. | 399.24 Million USD | -909.48% |
| Avinger, Inc. | 7.65 Million USD | -52569.89% |
| Azenta, Inc. | 665.07 Million USD | -505.995% |
| BioLife Solutions, Inc. | 143.27 Million USD | -2713.061% |
| The Cooper Companies, Inc. | 3.59 Billion USD | -12.165% |
| Daxor Corporation | 1.28 Million USD | -314640.554% |
| Ekso Bionics Holdings, Inc. | 18.27 Million USD | -21948.799% |
| Femasys Inc. | 1.07 Million USD | -375871.342% |
| GlucoTrack, Inc. | - USD | -Infinity% |
| Harvard Bioscience, Inc. | 112.25 Million USD | -3490.468% |
| ICU Medical, Inc. | 2.25 Billion USD | -78.401% |
| Intuitive Surgical, Inc. | 7.12 Billion USD | 43.427% |
| KORU Medical Systems, Inc. | 28.51 Million USD | -14032.643% |
| LeMaitre Vascular, Inc. | 193.48 Million USD | -1983.015% |
| Innovative Eyewear, Inc. | 1.15 Million USD | -349607.023% |
| Innovative Eyewear, Inc. | 1.15 Million USD | -349607.023% |
| Masimo Corporation | 2.04 Billion USD | -96.782% |
| Microbot Medical Inc. | - USD | -Infinity% |
| Meihua International Medical Technologies Co., Ltd. | 97.09 Million USD | -4050.716% |
| Merit Medical Systems, Inc. | 1.25 Billion USD | -220.535% |
| Nephros, Inc. | 14.23 Million USD | -28206.644% |
| NovoCure Limited | 509.33 Million USD | -691.282% |
| NEXGEL, Inc. | 4.08 Million USD | -98464.441% |
| NEXGEL, Inc. | 4.08 Million USD | -98464.441% |
| Singular Genomics Systems, Inc. | 2.91 Million USD | -138350.704% |
| OraSure Technologies, Inc. | 405.47 Million USD | -893.977% |
| Pro-Dex, Inc. | 53.84 Million USD | -7385.142% |
| Pulse Biosciences, Inc. | - USD | -Infinity% |
| Predictive Oncology Inc. | 1.78 Million USD | -226309.519% |
| Precision Optics Corporation, Inc. | 19.1 Million USD | -20996.242% |
| QuidelOrtho Corporation | 2.99 Billion USD | -34.442% |
| Repligen Corporation | 638.76 Million USD | -530.953% |
| Sanara MedTech Inc. | 64.98 Million USD | -6101.431% |
| STAAR Surgical Company | 322.41 Million USD | -1150.035% |
| Sharps Technology, Inc. | - USD | -Infinity% |
| Utah Medical Products, Inc. | 50.22 Million USD | -7924.65% |
| DENTSPLY SIRONA Inc. | 3.96 Billion USD | -1.647% |
| Jin Medical International Ltd. | 19.82 Million USD | -20233.016% |